Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545 |
filingDate |
1995-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
1996-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-960000893-A |
titleOfInvention |
Purification Method of Cephalosporin Salt |
abstract |
The present invention provides 7- [2- (2-aminothiazol-4-yl) -2- (Z)-hydroxyiminoacetamido] -3-N, N-dimethylcarbamoyl of formula (I). P-toluenesulfonic acid salts of oxymethyl-3-cepem-4-carboxylic acid (isopropoxycarbonyloxy) ethylesters, their use in the preparation of other salts and pharmaceutical compositions containing them. |
priorityDate |
1994-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |